Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-31

FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals' supplemental application for buprenorphine HCl and naloxone HCl (buprenorphine and naloxone), under an ANDA, for the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine HCl and Naloxone HCl (Buprenorphine and Naloxone)

Snippet

SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)